Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:BLK
NYSE:BLKCapital Markets

BlackRock Weighs Crypto ETF Flows And Retirement Rethink For Investors

BlackRock's Bitcoin ETF, iShares Bitcoin Trust (IBIT), recently saw record trading volumes alongside major outflows tied to institutional activity and derivatives volatility. The firm is also pursuing mergers among several closed end funds as part of a broader set of shareholder value initiatives. In his latest annual letter, CEO Larry Fink called for a fundamental rethink of the retirement age in America, putting BlackRock at the center of a high profile policy debate. For investors...
NYSE:ANET
NYSE:ANETCommunications

Arista’s AI Data Center Rise Confronts Valuation And Concentration Risks

Arista Networks (NYSE:ANET) is expanding its role as a key supplier of ultra fast Ethernet platforms for hyperscale AI data centers. The company is closely tied to cloud giants' AI infrastructure buildouts, supplying networking gear that supports large scale AI workloads. Management faces pressure on margins and customer concentration risks as a small group of major clients accounts for a large share of business. Arista Networks, which focuses on high performance networking solutions for...
XTRA:BAYN
XTRA:BAYNPharmaceuticals

Will OCEANIC-STROKE’s Asundexian Data Shift Bayer’s (XTRA:BAYN) Narrative on Innovation and Risk?

In early February 2026, Bayer reported pivotal Phase III OCEANIC-STROKE results showing its investigational Factor XIa inhibitor asundexian reduced recurrent ischemic stroke without increasing major bleeding versus placebo, both on top of antiplatelet therapy. A key insight from OCEANIC-STROKE is that asundexian delivered stroke risk reduction across all enrolled TOAST stroke subtypes, while maintaining a bleeding profile comparable to placebo. Against this backdrop, we’ll examine how the...